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Bilateral Optic Disc Drusen with Neuroretinitis
Abstract
Background: Neuroretinitis is an inflammation of the posterior pole of the eye, resulting in optic disc
edema and macular star formation. Systemic conditions associated with these findings include
tuberculosis, toxoplasmosis, syphilis, lyme disease, toxocariasis, mumps, herpes simplex, and cat scratch
disease. This case illustrates diagnosis and treatment for a patient with neuroretinitis complicated by
preexisting vision loss.
Case Report
Report: A Caucasian male in his 40’s presented to the eye clinic for an emergency appointment with
complaints of constant blurry vision, especially inferiorly upon awakening, in his right eye for the past two
weeks. His ocular history included optic disc drusen in both eyes with profound peripheral vision loss in
the left eye. The patient’s systemic history included cluster headaches and sleep apnea. Entering visual
acuities were 20/150- OD and 20/20 OS. Additional medical history questioning revealed the recent
adoption of a kitten.
Conclusion: This case describes the diagnosis and treatment for the rare condition of neuroretinitis
secondary to a Toxocara infection. While cat scratch disease was initially suspected, detailed laboratory
testing identified the true, and more rare, causative infectious agent. A variety of differential diagnoses
were ruled out through laboratory and imaging studies. Consultations with neuro-ophthalmology and
infectious disease specialists were exceedingly valuable in contributing to a positive outcome for this
patient. This patient’s preexisting ODD with vision loss heightened the concern to preserve the patient’s
remaining vision and further added to the complexity of this challenging case. The importance of medical
history questions regarding animal contact also proved vital for accurate diagnosis and treatment of this
sight threatening condition.

Keywords
Neuroretinitis, macular star, drusen

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 International
License.

This case report is available in Optometric Clinical Practice: https://athenaeum.uiw.edu/optometric_clinical_practice/
vol4/iss2/2

Kreinbrink et al.: Bilateral Optic Disc Drusen with Neuroretinitis

INTRODUCTION
Neuroretinitis is an inflammation of the posterior pole of the eye, resulting in a
classic triad of acute painless unilateral vision loss, optic nerve edema, and macular
star formation.1 The inflammation begins as a vasculitic process in the optic nerve
due to infectious or immune-mediated etiologies. Numerous systemic conditions
can be associated with these findings including tuberculosis, toxoplasmosis,
syphilis, Lyme disease, toxocariasis, mumps, herpes simplex, and cat scratch
disease. Additionally, diagnosing neuroretinitis can be clouded by other mimicking
ophthalmic conditions. This case illustrates treatment for a patient with
neuroretinitis complicated by preexisting vision loss. Appropriate laboratory tests
and differential diagnoses will also be described.
CASE REPORT
A Caucasian male in his 40’s presented to the eye clinic for an emergency
appointment with complaints of constant blurry vision in his right eye upon
awakening for the past two weeks. In the same eye, he also noted grey vision
inferiorly and light sensitivity. Eight years prior, the patient was diagnosed with
pseudo-papilledema secondary to buried optic disc drusen (ODD) following
computed tomography (CT), lumbar puncture, and intravenous fluorescein
angiography (IVFA) to rule out space occupying lesions and true optic disc edema.
At the time of diagnosis, crowded, elevated optic nerves were noted in each eye,
with peripheral vision loss in the left eye. Prior fundus photos (figure 1), Humphrey
visual field (HVF) tests (figure 2), and retina nerve fiber analysis (RNFL) reports
(figure 3) were available in his medical record.

Figure 1: (Baseline: two years prior) The color images of the right and left eyes reveal full, elevated, optic discs
as evidenced by the blood vessels cascading over the distinct disc margins onto the peripapillary retina.
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Figure 2: HVF 30-2 (Baseline: two years prior) The visual field of the right eye shows a nasal defect
greater inferiorly with a solitary inferior nasal point defect. The visual field of the left eye shows a
dense superior arcuate defect containing numerous absolute losses associated with an early inferior
nasal step. The reliability is borderline due to false negative errors.

Figure 3: RNFL (two years prior) The report demonstrates asymmetry in the measured optic disc
size and peripapillary RNFL thickness between the right and left eyes. Note the superior quadrant
thickness averages are similar between the eyes, however, there is advanced thinning of the left eye
inferiorly which accounts for the superior visual field defect demonstrated on the threshold visual
field test of the left eye. The horizontal and vertical tomograms demonstrate the elevated, full optic
nerves.
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The patient’s systemic history included cluster headaches and sleep apnea, with a
notation of nonadherence for sleep apnea treatment. The patient’s social history
revealed cigarette smoking 1.5 packs per day for 25 years, social alcohol
consumption, and no illicit drug use. Additionally, he reported adopting a new
kitten approximately 11 weeks prior. He denied any animal bite or scratch history
but did recall handling several animals in the shelter during the adoption process.
Entering uncorrected visual acuities were 20/150- OD and 20/20 OS. There was
no improvement with pinhole OD. Ocular motility was smooth and full, without
diplopia or pain. Pupils were equal and reactive, with a mild RAPD OD. The
external examination revealed normal slit lamp findings with quiet anterior
chambers and clear lenses OU. Internal examination of the right eye revealed 2+
vitreous cells, elevated optic nerve head margins, and macular edema with
exudative star formation in the right eye (see figure 4). The peripheral retina was
intact OU. In-office blood pressure measured 122/81mm Hg.

Figure 4: Right eye with neuroretinitis The color image demonstrates blurring of the disc margins
and presence of exudation in the fovea forming an early macular star surrounding a larger, central
foveal exudate. Additionally, there is a vitreous floater and small, discrete, pinpoint sized retina
pigment epithelial defects visible within the posterior pole inferior and temporal to the macula.

The internal examination of the left eye revealed a full and distinct nerve with flat
macula, normal vasculature and intact retina periphery (see figure 5).
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Figure 5: Left eye stable from baseline-The color image shows the stable nerve and fundus
appearance of the left eye when compared to the baseline posterior pole image. Note in this image
a subtle window defect superior to the optic disc seen under a retina arteriole. Additionally, there
are small, discrete pinpoint areas of RPE dropout throughout the fundus.

Figure 6: RNFL (day of emergent visit) This report demonstrates a relative increase in the
peripapillary RNFL thickness of the right eye. Note the ringlike pattern surrounding the optic disc
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(Figure 6 cont.) on the thickness map. The left eye’s thickness map is similar to baseline with the
exception of the inferior quadrant which appears to show progressive thinning.

The RNFL analysis revealed an increase in peripapillary RNFL thickness
compared to baseline in the right eye (see figure 6). The left eye retinal nerve fiber
layer thickness remained stable to baseline.
The macular thickness analysis report showed intraretinal and subretinal macular
edema with a foveal center thickness of 376 microns OD (see figure 7).

Figure 7: Macular thickness analysis report emergent visit - The macula thickness scan
demonstrates subfoveal and subretinal fluid near the temporal margin of the optic nerve of the right
eye. Additionally, hyperreflective, intraretinal deposits can be identified in this scan along with the
presence of a vitreous cell. The left eye horizontal b scan shows a relatively normal cross section of
the macula within this line scan of the left eye.

A HVF 30-2 test of the right eye revealed an enlarged blind spot corresponding to
the optic disc edema and peripapillary subretinal fluid, and a paracentral visual field
defect correlating to the presence of macular edema which is greater in the inferior
macula. The severe superior and inferior nasal visual field defects are presumably
from induced ischemia occurring at the optic disc due to reduced axoplasmic flow
and swelling of the ganglion cell axons,2 made worse by the crowding and presence
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of ODD in this eye. The threshold visual field of the left eye is reliable and shows
a severe, superior arcuate defect with early nasal step. Compared to baseline, this
visual field appears to be worse in the size and the depth of the defect as evidenced
by the number of absolute losses. This correlates to the RNFL report showing
progressive thinning of the inferior quadrant’s RNFL thickness. (see figure 8).

Figure 8: HVF 30-2 emergent visit

Intravenous fluorescein angiography (IVFA) was ordered that day and revealed
early leakage and late disc staining of the right eye without macular leakage. The
left eye revealed normal results highlighting a small retina pigment epithelium
(RPE) window defect in the superior retina.

Figure 9: IVFA right eye midphase – The fluorescein angiography image demonstrates
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(Figure 9 cont.) hyperfluorescence of the disc and disc vasculature. The arteriolar phase
is complete and the venous phase is mid to late with evidence of some residual laminar
flow. The macula does not show leakage and there are pinpoint areas of
hyperfluorescence scattered in the periphery consistent with the presence of minute RPE
defects observed in earlier color fundus images. The irregular shaped dark area inferior
nasal to the disc is an artifact from the vitreous.

Figure 10: IVFA late phase right eye – The optic disc continues to glow in the
late phase of the study confirming the presence of disc edema. The macular
region remains hypofluorescent without late macular leakage.

Figure 11 IVFA left eye – The mid phase angiography image for the left eye
demonstrates a hyperfluorescent disc with hyperfluorescence in the areas of
peripapillary atrophy as well as the window defect noted superiorly to the
nerve. The macular region is Hypofluorescent without leakage. Several
pinpoint sized RPE defects are observed in the retina periphery.

Laboratory orders included a complete blood count (CBC) with differential,
erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), tuberculosis (TB)
testing, toxoplamosis antibody testing, rapid plasma reagin (RPR), toxocara
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antibodies, Bartonella antibodies, angiotensin converting enzyme (ACE), and
lysozyme. A neuro-ophthalmology appointment was scheduled for the following
day.
NEURO-OPHTHALMOLOGY VISIT 1

The patient returned the next day with unchanged visual acuity, history, and ocular
status OU. Lab results from the prior day revealed a slightly elevated CRP, normal
ESR, negative syphilis screening, and essentially normal CBC with differential.
Lymph nodes were checked in the office and were found to be normal. However,
the patient reported a “knot” in his right jaw roughly two weeks prior that resolved
in about one day. The patient was tentatively diagnosed with cat scratch disease
(CSD) and after discussing risks and benefits was started on oral doxycycline
100mg bid and rifampin 300mg bid for two weeks.
Additional laboratory orders were placed for liver function tests (due to the
rifampin order), herpes simplex virus (HSV) IgM antibodies, varicella zoster
(VZV) IgM antibodies, and the patient was scheduled for a progress check in two
weeks. Lab results returned with normal and negative findings for all tests with the
exception of toxocara antibodies. The neuro-ophthalmologist was alerted about the
test results and requested a consultation for the patient with an infectious disease
(ID) specialist. The patient was also contacted with the lab results and notified of
the recommended infectious disease consult. Two days later the patient phoned the
clinic to report he had his cat tested for toxocara and the results were negative.
NEURO-OPHTHALMOLOGY VISIT 2

Two weeks later the patient returned with stable vision, history, and ocular status.
Plans included stopping oral doxycycline and rifampin and to keep his scheduled
infectious disease consult for later that same day. The patient was diagnosed with
neuroretinitis due to toxocariasis.
INFECTIOUS DISEASE CONSULTATION SUMMARY

The patient was examined, and the following tests were ordered: MRI brain, CT
chest/abdomen to rule out visceral larva migrans (VLM), and lumbar puncture (LP).
Additional blood work included strongyloides antibodies, Epstein-Barr Virus
(EBV), cytomegalovirus (CMV), and human immunodeficiency virus (HIV). Lab
testing, MRI brain, and CT abdomen results were all negative. The ID specialist
initiated treatment for toxocariasis. The patient was placed on oral albendazole 800
mg daily for thirty days and oral prednisone tapered as follows: 60 mg daily for 7
days, then 40 mg daily for 7 days, then 20 mg daily for 7 days, then 10 mg daily
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for 7 days, then 5 mg daily for 7 days, and then discontinue. The patient was reexamined 5 weeks later by the ID specialist and released back to neuroophthalmology.
NEURO-OPHTHALMOLOGY VISIT 3

Three months after the initial visit the patient returned with stable vision (20/150
OD and 20/20 OS) and medical history. The RNFL and macula scan reports showed
a reduction in optic nerve swelling and macular edema of the right eye. No further
treatment was indicated, and the patient was advised to return in one month for
follow up.
NEURO-OPHTHALMOLOGY VISIT 4

The following month the patient returned with greatly improved uncorrected
vision in the right eye to 20/25 and stable vision in the left eye at 20/20. The
macula thickness remained stable OD, OS. The patient was advised to return in 3
months for a follow-up visit.

Figure 12: Macula change analysis report right eye - The macula change analysis report
shows a drastic reduction of retinal edema from the initial emergent visit to four months
(Figure 12 cont.) later, restoring normal retinal architecture and function as evidenced by
improved visual acuity. A residual, intraretinal, hyperreflective deposit is observed in the
cross section of this image representing a hard exudate.
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NEURO-OPHTHALMOLOGY VISIT 5

Seven months after the initial visit the patient returned with complaints of blurry
distance vision in the right eye and altered depth perception. Unaided acuity was
20/20- OD and 20/20 OS. Amsler grid testing revealed subtle metamorphopsia in
the right eye and normal findings in the left eye. The macula thickness scan was
stable with the presence of fine scattered hyperreflective deposits in the right eye.
The left eye remained unchanged. Plans included monitoring the patient’s status in
6 months with the neuro-ophthalmologist with no further treatment indicated.
DISCUSSION
Distinguishing optic disc drusen from early disc edema can be a challenging task.
It is worth reviewing ODD in light of our patient’s history and initial clinical
presentation, particularly due to the pre-existing vision loss in the left eye, and the
onset of new vision loss in the right eye.
Drusen of the optic disc have been described for over 100 years in the ophthalmic
literature.3,4 “Druse” is a word of German origin describing a crystal lined hollow
space in a rock.5 Clinically, disc drusen near the surface are easily diagnosed by
their characteristic lumpy appearance. They are often located more nasally 4 in the
optic nerve and can be confirmed with additional tests including fundus
autofluorescence imaging (FAF), ultrasonography, and OCT. The incidence of
clinically diagnosed disc drusen has been estimated to be 0.3-0.5%.6 Disc drusen
below the surface may go unnoticed clinically. Surface drusen tend to be more
common in older patients and these nerves proportionally are prone to have a
greater volume of ODD compared with those whose drusen are "buried."7 Optic
disc drusen may resemble optic disc edema and on occasion may present with disc
hemorrhage and visual field defects.8
If optic disc edema is suspected in a patient with pre-existing ODD, one way to
determine if there is a status change is to review baseline RNFL scans for
comparison (as in our patient). Furthermore, changes in the RNFL values can be
analyzed to aid diagnosis of worsening disc edema in the presence of disc drusen
and utilized again over time to assess RNFL loss from axonal damage following an
episode of disc edema.7
Optic disc drusen appear on OCT as internally hyporeflective structures with a
full or partial hyperreflective margin superiorly. They are located anterior to the
lamina cribrosa and they may occur in clusters or single entities and are often
adjacent to the nasal border of optic disc.9,10
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The analysis and composition of ODD has consistently shown the presence of
calcium.4,6 There are reports in the literature of hereditary tendencies 4,5 with
bilateral presentations occurring up to 80% of the time.4 Optic disc drusen can
compress axons of the optic nerve.3 ODD may cause a crowding effect leading to
physical changes in the nerve promoting RNFL loss and subsequent VF defects.11,12
VF defects have been shown to be more prominent with superficial ODD and
present in up to 87% of patients diagnosed with ODD.5 Additional ODD
complications may include anterior ischemic optic neuropathy(AION), choroidal
neovascular membranes (CNVM), hemorrhages, and central retinal artery or vein
occlusions.5,6 Optic disc drusen may be an independent risk factor for non-arteritic
anterior ischemic optic neuropathy (NAAION).12 There are multiple disease
associations both ocular and systemic with ODD, including retinitis pigmentosa
(RP), pseudoxanthoma elasticum (PXE), and angioid streaks. 5,6
Challenges may exist in the OCT interpretation of ODD since they may be
confused with peripapillary hyperreflective ovoid mass-like structures (PHOMS)
or blood vessel lumens.7,10 Although oval and hyperreflective, PHOMS do not
show a hollowed central core like ODD, do not autofluoresce, and cannot be
distinguished with ultrasonography. They are presumably composed of herniated
axons within the peripapillary region of the optic nerve.13 Blood vessel lumens can
be recognized by a more densely hyperreflective surface from their vascular walls.
Their columnar shadowing and the ability to cross reference their location on the
optic disc will help to differentiate them from ODD.

Figure 13: Baseline OCT line scans right eye and left eye - The patient’s baseline high definition
line scans of the right and left eye two years prior. Note the hyperreflective surface signal
followed by the hyporeflective core on the images.
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Neuroretinitis was first described in 1916 by Leber who termed the condition
idiopathic stellate maculopathy after believing it to be a disorder of the macula.1,14
It was later determined by Gass that the optic nerve was affected prior to the
presentation of the macular star, suggesting “neuroretinitis" as a more appropriate
descriptor.1 The classic clinical triad of neuroretinitis is characterized by acute
unilateral vision loss, optic nerve edema, and the formation of a macular star due
to the arrangement pattern of macular exudates.1,15 This inflammation of the optic
nerve and peripapillary retina may also present with a vitritis and other deep white
retinal lesions.1,16
Neuroretinitis begins as a vasculitic process in the optic nerve that causes leakage
of lipid-rich fluid through the outer plexiform layer of the retina which leads to the
formation of the macular star.15,16 While macular exudates may not be clinically
evident until up to six weeks following the onset of symptoms, earlier detection
using optical coherence tomography and fundus autofluorescence can aid in a more
timely diagnosis.1 Neuroretinitis affects all ages, but more often in the third and
fourth decades of life.15 Visual acuity at presentation ranges from 20/20 to light
perception.15 The most common visual field defect is a cecocentral scotoma, but
central scotomas, arcuate defects and even altitudinal defects may also be present.
An afferent pupil defect RAPD is present in most patients unless bilateral.15
The etiology of neuroretinitis is thought to be infectious or immune mediated.15
While neuroretinitis often presents with a viral prodrome, viral agents are rarely
discovered from these cases.15 Herpes simplex, hepatitis B, mumps, herpetic acute
retinal necrosis syndrome, and cytomegalovirus have been listed as potential viral
causes.15,17
Neuroretinitis is often misdiagnosed.15 One study found that as many as 35% of
neuroretinitis case referrals were actually other diseases presenting with optic nerve
edema and a macular star.1 The most common mimicker was malignant
hypertension (43%), followed by idiopathic intracranial hypertension (14%),
diabetic papillopathy (14%), branch retinal vein occlusion (12%), and finally
anterior ischemic optic neuropathy (7%).1 Diagnosis can be further complicated
due to the lack of macular star formation at initial examination. Stellate macular
exudates typically occur 2-6 weeks following onset of the optic nerve edema. 1
Neuroretinitis presents unilaterally, in contrast to many of the differential
diagnoses which present bilaterally. Malignant hypertension is typically bilateral,
but may be asymmetric.18, 19 Idiopathic intracranial hypertension (IIH) can also
result in papilledema with secondary macular edema due to both mechanical and
hemodynamic changes at the optic nerve spreading to the peripapillary area and
macular region.20 In the presence of bilateral disc edema, a space occupying lesion
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must be ruled out. If imaging rules this out, infiltrative etiologies should also be
considered. However, it is more common for infiltrative neuropathies to present
unilaterally, with a more nodular or mass-like appearance of the optic nerve and
with more severe vision loss.21,22 Papillitis associated with multiple sclerosis
presents with optic nerve edema in about one third of optic neuritis cases. These
cases rarely have an associated macular star, especially prior to a definitive
diagnosis of multiple sclerosis.23
Anterior ischemic optic neuropathy may also be mistaken for a neuroretinitis as it
involves unilateral painless vision loss with associated optic nerve edema.15
Macular edema is rare in this condition, but spillover edema from the optic nerve
is possible.24 Nonarteritic ischemic optic neuropathy, arteritic anterior ischemic
optic neuropathy (AAION), giant cell arteritis, and central retinal vein occlusion
should all be considered in the differential diagnosis of neuroretinitis.

Neuroretinitis Malignant
Idiopathic
Diabetic
Retinal Vein
Hypertension Intracranial Papillopathy Occlusion
Hypertension
Laterality

Unilateral

Bilateral

Bilateral

Pupils

(+)APD

(-)APD

(-)APD

Physical
Disc edema,
examination macular star,
possible
vitritis

Disc edema,
macular star

Disc edema,
possible
macular star

Symptoms

Headache,
nausea, chest
or back pain,
dyspnea,
orthopnea

Headaches,
nausea,
dizziness, neck
pain

Uncontrolled
blood
pressure,
>180/120

Female,
obesity,
endocrine
disorders

Fever, fatigue,
headaches,
lymph node
swelling

Risk factors/ Exposure to
Associations infectious or
parasitic
diseases,
animal or
insect bites,
raw meat
ingestion

Unilateral or Unilateral
Bilateral
(-)APD
(+)APD,
depending on
severity
Disc edema, Hemorrhaging,
often with
exudates,
severe
possible
diabetic
macular and
retinopathy disc edema
Often
Often
asymptomatic asymptomatic

Uncontrolled
type 1 or
type 2
diabetes

Anterior
Papillitis
Ischemic
Optic
Neuropathy
Unilateral Unilateral
(+)APD

(+)APD

Disc edema, Disc
rarely
edema
macular
edema
Arteritic:
scalp
tenderness,
jaw
claudication,
temporal
pain

Hypertension, Giant cell
hyperlipidemia, arteritis,
diabetes,
crowded
increasing age, nerves,
blood
sleep apnea,
hyperviscosity, nocturnal
open angle
hypotension,
glaucoma
smoking

Pain with
eye
movement,
balance
problems,
fatigue,
bladder
dysfunction
Multiple
sclerosis

Table 1: Common differentials and misdiagnoses of neuroretinitis 1,15,30,31,32

Our patient was initially diagnosed with and treated for cat scratch disease based
on the presence of neuroretinitis and the patient’s history of a recent kitten adoption.
Cat scratch disease is the most common infectious cause of neuroretinitis and is
caused by Bartonella henselae, a gram-negative bacillus, contracted through cat
bites or scratches.1,16,28 In 2016 it was estimated that 12,500 individuals are
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diagnosed with CSD annually in the United States.29 Most patients diagnosed with
CSD report a history of close contact with cats.17 It is often self-limiting and
presents with a papule at the inoculation site several days after the break in skin.
Regional lymphadenopathy follows in 90% of cases, and systemic symptoms such
as fever, fatigue, and headaches occur in about 50% of cases.29,28 Atypical
manifestations, occurring in about 10% of CSD patients, include neurologic,
dermatological, musculoskeletal, hepato-splenic, and most commonly, ophthalmic
involvement.29,28
Several inflammatory ocular conditions are associated with CSD. A large study
found 88% of ocular CSD presented with swollen optic nerves; 79% of these cases
were diagnosed with neuroretinitis at some point in the disease presentation,
making neuroretinitis the most common ophthalmic manifestation of CSD.29 Other
ophthalmic findings included: parinaud oculoglandular syndrome, anterior uveitis,
retrobulbar neuritis, chorioretinitis, retinal vessel occlusion, and panuveitis.29 One
study found that the presence of a peripapillary serous retinal detachment in the
presence of optic disc edema may be an early sign of B. henselae infection even in
the absence of associated chorioretinitis and macular star formation (which may
take weeks to develop).30
Treatment of ocular CSD has been controversial, as the infection is often selflimiting.29 However, studies have found that while treatment shows no effect on
final visual acuity, antibiotic therapy can speed visual recovery.29 In 1998 a
retrospective case series evaluated seven cat-scratch neuroretinitis patients treated
with oral doxycycline and rifampin and concluded that antibiotic treatment
shortened the disease course.29 This treatment regimen has since been adopted by,
and published in, medical journals and textbooks.29 A study in Japan isolated 32
strains of B. henselae to investigate antibiotic susceptibility. They found a high
susceptibility to antibiotic treatment and concluded that macrolides and
minocycline can be reliable options when treating CSD.31 Another study found that
compared to antibiotics alone, a combination of systemic antibiotics and
corticosteroids was superior in treating moderate to severe infections.29 In healthy
individuals, neuroretinitis due to ocular CSD has a good prognosis with often
complete or near-complete recovery.30 However, contrast sensitivity, visual evoked
potentials, and color vision may be subnormal or abnormal following severe
disease.30
Other infectious and parasitic diseases should be considered in the differential
diagnosis of a neuroretinitis etiology. In addition to previously mentioned viral
conditions, bacterial agents including, tuberculosis, syphilis, Lyme borreliosis,
leptospirosis, and rickettsiosis with parasitic infections including toxocariasis,
toxoplasmosis, angiostrongyliasis, cysticercosis, gnathostomiasis, thelaziasis, and
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trichinosis 15,16,17 should remain on the differential.
Lastly, there are other ocular conditions that may present with neuroretinitis which
have unique characteristics that are worth mentioning. Diffuse unilateral subacute
neuroretinitis (DUSN) is thought to be caused by helminths with intraocular worms
visible in about 25% of cases.15 DUSN typically presents more insidiously with
severe vision loss, neuroretinitis, vitritis, and pigmented epithelial derangements,
often in healthy young patients. Many patients present in later stages; the disease
progresses to optic atrophy and narrowing of vessels if left untreated.32 Another
similar condition is Idiopathic Retinal Vasculitis and Aneurysms associated with
Neuroretinitis (IRVAN) which presents with characteristic microaneurysms in
arterioles. This is commonly found bilaterally in young, otherwise healthy
females.15
Histologic proof of human nematode infection of the eye was made nearly 70
years ago and Toxocara canis and Toxocara cati were morphologically identified
in humans.33 Toxocariasis now represents the most prevalent of human helminthic
infections in the industrialized world.34,35 The roundworms are capable of
producing thousands of eggs per day. The eggs are shed within the feces of infected
animal hosts and have the ability to remain viable in the soil for several months or
even years. If accidentally ingested by human hosts through poor hygiene practices
or through consumption of raw meat from animals infected with larvae, the eggs
can hatch in the human intestine and then enter the portal circulation.36-38 Three
types of toxocara infection syndromes are recognized including visceral larva
migrans (VLM), covert toxocariasis (CT), and ocular toxocara (OT).36,37
Presenting systemic symptoms of VLM are varied and numerous often including
fever and cough in the presence of elevated IgE levels. A severe systemic invasion,
especially in children, may result in symptoms of fever, hepatosplenomegaly,
pneumonitis, and convulsions. 18,34,36,39
Covert toxocariasis (CT) results in more vague symptoms including coughing,
sleep disturbances, abdominal pain, headaches, nausea, or cervical lymphadenitis.36
Ocular toxocariasis (OT) is the most common presentation and may manifest as
endophthalmitis, chorioretinal granulomas, or neuroretinitis.36,38 Symptomatic
vision loss from OT stems from direct retinal damage from granuloma formation,
the secondary effects of retina damage (edema, tractional bands, retinal
detachments), and intraocular inflammation.40,41 While ocular inflammation is
often severe, ocular pain is rare and therefore, many cases of OT are found during
routine examination.42 Ocular complications result from an immune response to the
presence of toxocara larvae in the eye. The most common ocular complication is
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posterior pole and peripheral granulomas, while the most visually devastating is a
tractional retinal detachment secondary to inflammatory fibrosis.42 Importantly, the
clinical observation of a migrating granuloma is pathognomonic for ocular
toxocariasis.40 Neuroretinitis from toxocara is a rarer presentation and has been
reported in only 7.2% of all ocular toxocariasis cases.43
OCT associated findings specific to neuroretinitis may include the presence of
vitreous cells and appearance of infiltrates on the optic nerve head which have been
noted to precede the presence of macular star formation. Concentric ring patterns
have been observed on the inner retina expanding outward from disc when using
en face analysis on OCT at the vitreoretinal interface.44
About 5% of the US population, or 12 million people, test seropositive for
toxocariasis.35,41,45 These numbers may be even higher in rural areas 36 where
infection rates remain higher in men, children, and minority ethnicities.35,42 In some
parts of the world there is a high prevalence of seropositivity for toxocara associated
with the consumption of raw meat.34,46

Figure 14: Descriptive OCT line scan of the right eye at the emergent visit

Definitive diagnosis of ocular toxocariasis can be made with direct observation of
the presence of larvae in ocular tissue.43 However, this is rare and diagnosis is
typically made based on exposure history, clinical examination, and laboratory
blood analysis including toxocara antibodies.18,38 The recommended diagnostic
testing sequence today for toxocariasis includes enzyme-linked immunosorbent
assay (ELISA)46-48 followed by immunoblot testing.49 A newer assay testing for
rTc-CTL-1 antigen to toxocara has shown 90% sensitivity and 99% specificity and
may provide more reliable results.35 The absence of serum antibodies does not
necessarily exclude toxocariasis as a diagnosis as there have been reports of ocular
toxocariasis in seronegative patients presumably due to low titer levels as the
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infection is localized to the eye.42,46 For our patient, the laboratory used the ELISA
method for detecting toxocara antibodies, however, it did not subsequently order
confirmatory immunoblot testing as suggested above.
Elevated IgE and eosinophilia are also common in helminthic infections. Some
studies have used IgE elevation to support toxocariasis diagnosis following a
positive Western Blot.38 One study found that 17 out of 22 seropositive patients had
elevated IgE serum levels.43 It is estimated that toxocariasis infection has a
prevalence of 80% in dogs aged between 2-6 months old and between 10-75% for
cats.34 A history of close contact with pets should be investigated in every OT
patient, and if affirmative, these pets should be evaluated by a veterinarian.50
The decision to initiate treatment in a seropositive patient is made when there are
symptoms and evidence of end organ damage. Currently, the treatment of choice is
oral albendazole as it penetrates the gastrointestinal tract and crosses the blood
brain barrier.39
Albendazole is an antiparasitic agent from the class of medications known as
benzimidazoles.51 It has a broad spectrum in the treatment of multiple helminthic
infections 38,50 and the mechanism of action involves binding selectively to parasite
tubulins preventing polymerization. Albendazole has a beneficial low likelihood
for human toxicity.36 Common side effects may include nausea, vomiting and
stomach pain, and elevated liver enzymes. Side effects are generally short term and
are typically tolerable.51
Steroids are used in the treatment of OT, since potential immunologic reactions
resulting from dying larvae can cause damaging ocular inflammation. 36 Both
topical and systemic corticosteroids are utilized to treat acute active inflammation
associated with OT depending on its location and severity.40 In contrast, when
treating VLM (systemic toxocariasis), steroid alone treatment is dangerous as
larvae migration may be enhanced.36 In most instances of OT with active
inflammation and positive serology, a combination treatment using albendazole and
corticosteroids is used although some controversy exists with albendazole therapy
due to a lack of randomized controlled trials.36,40,46,48,49
A retrospective cohort study by Ahn46 in 2014 involving steroids and albendazole
was completed to assess treatment outcomes for patients diagnosed with OT. A
total of 101 adult patients were enrolled with nearly 70% of patients exhibiting
elevated serum IgE levels. Patients were treated with medication or surgery
depending on their retina status, symptoms, and level of inflammation. Those
treated with medication received topical and/or oral corticosteroids (0.51mg/kg/day) depending on the presence and/or location of the ocular inflammation.
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Additionally, if there was elevated serum IgE or eosinophilia, then oral albendazole
400mg bid P.O. x 2 weeks was added to the treatment regimen.
From this treatment stratification, four distinct groups emerged:
1. Steroid and albendazole therapy (inflammation and elevated IgE or

eosinophilia)
2. Albendazole only (no inflammation but elevated IgE or eosinophilia)
3. Steroid only (inflammation only without elevated IgE or eosinophilia)
4. No treatment (no inflammation, no elevated IgE or eosinophilia)

Patients with follow-ups of greater than 3 months duration were monitored for
recurrence and treatment outcomes to include best corrected visual acuity (BCVA)
and level of inflammation. At 3 months, there were no significant changes in
BCVA for any group, however the steroid treated groups had a significant reduction
in ocular inflammation. In those groups with ocular inflammation there was no
difference between the steroid only and steroid and albendazole treatment group in
BVCA or inflammation. At the 6-month mark, the recurrence rate in the combined
therapy group (steroid with albendazole) was significantly lower than the steroid
only group. (17.4% vs 54.5%). There were no differences in recurrence in the eyes
without inflammation groups (albendazole only vs untreated).46
In summary, although albendazole did not have an impact on improving BCVA
outcomes, it seems that it may have a role in lowering the recurrence rate of OT in
eyes demonstrating inflammation.46
Our patient’s neuroretinitis treatment protocol was similar but not identical to the
aforementioned study protocol. The similarity includes the combination therapy
approach with the use of oral albendazole and oral steroids. The differences include
the dose and duration of our treatment with the albendazole therapy (800 mg for 30
days). In contrast to the study results, the BCVA outcome was favorable for our
patient. Additionally, our patient has experienced no recurrence of his OT. This
case underscores the potential benefits of treating patients with OT using the
combination therapy of albendazole with steroids, especially when the patient has
pre-existing vision loss.
CONCLUSION
This case describes the diagnosis and treatment for the rare condition of
neuroretinitis secondary to a toxocara infection. While cat scratch disease was
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initially suspected, detailed laboratory testing identified the true, and more rare,
causative infectious agent. A variety of differential diagnoses were ruled out
through laboratory and imaging studies. Consultations with neuro-ophthalmology
and infectious disease specialists were exceedingly valuable in contributing to a
positive outcome for this patient. This patient’s preexisting ODD with vision loss
heightened the concern to preserve the patient’s remaining vision and further added
to the complexity of this challenging case. The importance of medical history
questions regarding animal contact also proved vital for accurate diagnosis and
treatment of this sight threatening condition.
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